More speed on least burdensome provision, urge companies
This article was originally published in Clinica
Executive Summary
The Medical Device Manufacturers Association (MDMA) has asked the FDA to expedite its acceptance of a May 3 draft guidance which interpreted the least burdensome provisions of the FDA Modernization Act of 1997.